Fujifilm Irvine Scientific completes construction of Netherlands production facility, enters validation stage

Fujifilm Irvine Scientific joined the Fujifilm corporation through a 2018 buyout.

Fujifilm Irvine Scientific, a California-based provider of materials used throughout the medical supply chain, has completed construction on a new facility in the Netherlands.

The 250,000-square-foot factory, located in Tilburg, will produce dry powder media, liquid media and other raw materials. The facility will boost the company's production capacity by more than 320,000 kilograms of dry powder and 470,000 liters of liquids at the start of operation.

With the construction complete, the project now moves into the validation stage. Fujifilm Irvine Scientific expects the site to officially open in late 2021.

“The new facility will enable Fujifilm Irvine Scientific to meet increased global demand for cell culture media, as well as provide our European customers with a regional hub that delivers best-in-class cell culture media products and service," Fujifilm Irvine Scientific CEO Yutaka Yamaguchi said in a statement.

RELATED: Fujifilm expands its healthcare footprint with $800M acquisition of cell-culture manufacturers

The plant, which is the former site for producing Fujifilm photographic materials, uses sustainable technology like biomembranes to purify wastewater and generates 100% renewable electricity from wind energy.

Based in Santa Ana, California, Fujifilm Irvine Scientific is a producer of cell culture media, reagents, and medical devices. Aside from its forthcoming Netherlands site, the company operates plants in the United States and Japan. The company joined the Fujifilm corporation through a 2018 acquisition.

Editor's note: This story was updated to correctly reference the company that completed the construction project, Fujifilm Irvine Scientific.